ASH
ASHLAND INC.
NYSE · CIK 1674862
Last close69.52
Daily change+0.91 (1.33%)
10 Years gain+46.20%
Dividends TTM1.67 (+1.83%)
Dividend yield2.43%
Fundamental Analysis
ASH · STANDARD
SIC 5160 · Wholesale-Chemicals & Allied Products · Fiscal year end 0930
Fundamental
23.8Momentum
0.0Acceleration
0.0Confidence
90.0Annual Revenue12
Quarterly Revenue41
Annual CFO0
Balance SheetAvailable
RankingLimited
Score Breakdown
Growth0.0 / 25
Quality3.0 / 25
Capital Efficiency1.8 / 20
Balance Sheet7.9 / 15
Shareholder Economics9.8 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 0.1017 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 2.1277%.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Operating margin compression · MEDIUMOperating margin compressed by 26.1859 percentage points.
ROIC declining · MEDIUMROIC declined by 11.8337 percentage points.
Key Metrics
Revenue Growth TTM-8.74%OK
Revenue CAGR 3Y-8.63%OK
Gross Margin30.31%OK
Operating Margin-34.57%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-15.29%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-2.13%OK
SBC / Revenue0.82%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Sep 30, 2025 | $1.82B | $549.00M | -$775.00M | n/a | n/a | 30.1% | -42.49% | n/a | -17.52% | 46M |
| 2025 FY Sep 30, 2024 | $2.11B | $618.00M | -$26.00M | n/a | n/a | 29.25% | -1.23% | n/a | -0.52% | 50M |
| 2025 FY Sep 30, 2023 | $2.19B | $668.00M | $172.00M | n/a | n/a | 30.49% | 7.85% | n/a | 4.17% | 54M |
| 2024 FY Sep 30, 2022 | $2.39B | $830.00M | $333.00M | n/a | n/a | 34.71% | 13.93% | n/a | 7.01% | 56M |
| 2023 FY Sep 30, 2021 | $2.11B | $670.00M | $192.00M | n/a | n/a | 31.74% | 9.1% | n/a | 3.09% | 61M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.83B | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-324226, 0001193125-26-035054 |
| Revenue Growth TTM | -8.74% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-324226, 0001193125-26-035054 |
| Revenue CAGR 3Y | -8.63% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-25-289248 |
| Revenue CAGR 5Y | -1.98% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-25-289248 |
| Gross Profit CAGR 3Y | -12.87% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-25-289248 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001193125-26-324226, 0001193125-26-035054 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 30.31% | Gross Profit / Revenue | OK | 0001193125-26-324226, 0001193125-26-035054 |
| Operating Margin | -34.57% | Operating Income / Revenue | OK | 0001193125-26-324226, 0001193125-26-035054 |
| ROIC | -15.29% | NOPAT / Average Invested Capital | OK | 0001193125-26-324226, 0001193125-26-035054 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-324226 |
| Current Ratio | 3.05x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.32x | (Cash + Short-term Investments) / Total Debt | OK | 0001193125-26-324226 |
| SBC / Revenue | 0.82% | SBC / Revenue | OK | 0001193125-26-324226, 0001193125-26-191380 |